[1]
Setiawan, D., Tjandrawinata, R.R., Lianawati, Galar Sigit Prasuma, Andi Nurul Annisa and Sidartawan Soegondo 2025. The Use of Inlacin in Type 2 Diabetes Mellitus Management in Indonesia: A Cost-Effectiveness Analysis of Real-World Evidence. Indonesian Journal of Pharmacy. (Feb. 2025). DOI:https://doi.org/10.22146/ijp.12803.